Phase 4
Completed N=444
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Source: ClinicalTrials.gov NCT02098369 ↗Enrolled (actual)
444
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcomePrimary: Adherence to Supplemental O2 Prescription — 77; 73; 97 Participants
◆ Published Evidence
Emerging
2citations · ~1 / year
A Hybrid Effectiveness/Implementation Clinical Trial of Adherence to Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease.
Summary
About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life. Patients often do not use their oxygen as prescribed, which means that they are not benefiting as much as they could be from this therapy. The purpose of this study is to evaluate whether a PEer-Led O2 Infoline for patients and CAregivers (PELICAN) will increase adherence to supplemental oxygen prescription and improve health in patients with chronic obstructive pulmonary disease (COPD).
Linked Publications
-
A Hybrid Effectiveness/Implementation Clinical Trial of Adherence to Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adherence to Supplemental O2 Prescription |
77; 73; 97 | — |
| SECONDARY PROMIS - Physical Function |
-0.5; -0.1; -0.2 | — |
| SECONDARY PROMIS - Fatigue |
0.1; -1.0; 0.3 | — |
| SECONDARY PROMIS - Emotional Distress - Anxiety |
0.3; -1.2; -0.1 | — |
| SECONDARY PROMIS - Sleep Disturbance |
-0.4; -2.1; -0.8 | — |
| SECONDARY PROMIS - Emotional Distress - Depression |
1.1; -1.8; 0.5 | — |
| SECONDARY PROMIS - Satisfaction With Social Roles and Activities |
0.5; 0.2; -1.2 | — |
| SECONDARY PROMIS - Ability to Participate in Social Roles and Activities |
1.0; 1.4; 0.9 | — |
Eligibility Criteria
Inclusion Criteria
- Age 18 years or older.
- Physician diagnosis of COPD
- Physician prescription for home O2 for 24hrs/day, 7 days/week
- Willing to use home O2.
- Working telephone number.
Exclusion Criteria
- Unable to read and speak English.
- Discharge to home hospice or expected survival less than 6 months.
Data sourced from ClinicalTrials.gov (NCT02098369) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.